Senator Hatch Calls Out IPR Flaws

Senator Hatch Calls Out IPR Flaws

During today’s Senate Judiciary hearing, Senator Orrin Hatch addressed the dysfunctional interplay of the inter partes review system with the well-established Hatch-Waxman patent review process.

BIO shares Senator Hatch’s view that the unintended consequences created by the America Invents Act add unproductive litigation pressure on innovators and disrupt the balanced procedures that have historically made the Hatch-Waxman Act a success.

Read the full remarks, as prepared for delivery

Filed under: Patently BIOtech, , , ,